NCT00000134 arm group f076fe1b7165f6c36d8d35e8a5972044 [clinicaltrials_resource:NCT00000134/arm-group/f076fe1b7165f6c36d8d35e8a5972044]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00000134 arm group f076fe1b7165f6c36d8d35e8a5972044 [clinicaltrials_resource:NCT00000134/arm-group/f076fe1b7165f6c36d8d35e8a5972044]
Bio2RDF identifier
NCT00000134/arm-group/f076fe1b7165f6c36d8d35e8a5972044
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 76fe1b7165f6c36d8d35e8a5972044
description [clinicaltrials_vocabulary:description]
combination therapy, wherein p ...... nd ganciclovir at 5 mg/kg/day.
identifier
clinicaltrials_resource:NCT00000134/arm-group/f076fe1b7165f6c36d8d35e8a5972044
title
NCT00000134 arm group f076fe1b7165f6c36d8d35e8a5972044
@en
type
label
NCT00000134 arm group f076fe1b ...... 6fe1b7165f6c36d8d35e8a5972044]
@en